Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Watkins, Anne E.; Fenichel, Eli P.; Weinberger, Daniel M.; Vogels, Chantal B. F.; Brackney, Doug E.; Casanovas-Massana, Arnau; Campbell, Melissa; Fournier, John; Bermejo, Santos; Datta, Rupak; Dela Cruz, Charles S.; Farhadian, Shelli F.; Akiko Iwasaki; Ko, Albert I.; Grubaugh, Nathan D.; Wyllie, Anne L.; Iwasaki, Akiko (AUTHOR); Yale IMPACT Research Team2 (CORPORATE AUTHOR)
- Source:
Emerging Infectious Diseases. Apr2021, Vol. 27 Issue 4, p1184-1187. 4p.
- Additional Information
- Subject Terms:
- Abstract:
We analyzed feasibility of pooling saliva samples for severe acute respiratory syndrome coronavirus 2 testing and found that sensitivity decreased according to pool size: 5 samples/pool, 7.4% reduction; 10 samples/pool, 11.1%; and 20 samples/pool, 14.8%. When virus prevalence is >2.6%, pools of 5 require fewer tests; when <0.6%, pools of 20 support screening strategies. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.